In-vitro approaches for cefiderocol susceptibility testing and interpretation in the context of recent Clinical & Laboratory Standards Institute advisory

被引：0

作者：

Bakthavatchalam, Yamuna Devi ^{[1
]}

Walia, Kamini ^{[2
]}

Manoharan, Yuvashri ^{[1
]}

Veeraraghavan, Balaji ^{[1
]}

机构：

[1] Christian Med Coll & Hosp, Dept Clin Microbiol, Vellore 632004, India

[2] Indian Council Med Res, Div Epidemiol & Communicable Dis, New Delhi, India

来源：

关键词：

D O I：

10.1016/j.ijmmb.2024.100622

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页数：2

共 5 条

[1]

Clinical and Laboratory Standards Institute, 2024, M100-Ed34

Kidd, James M. ;

Abdelraouf, Kamilia ;

Nicolau, David P. .

[3] New Perspectives on Antimicrobial Agents: Cefiderocol [J].

McCreary, Erin K. ;

Heil, Emily L. ;

Tamma, Pranita D. .

Morris, C. Paul ;

Bergman, Yehudit ;

Tekle, Tsigedera ;

Fissel, John A. ;

Tamma, Pranita D. ;

Simner, Patricia J. .

Simner, Patricia J. ;

Patel, Robin .